Filters
Catalog peptides
Synthesis of unnatural amino acids and other blocks

Somatostatin-14

Name
Somatostatin-14
Molecular structural formula
Purity
≥95%
CAS Number
38916-34-6
Formula
C76H104N18O19S2
MW
1637.9
Target
others
Sequence
Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys (Disulfide bridge:Cys3-Cys14)
Sequence Shortening
AGCKNFFWKTFTSC (Disulfide bridge: Cys3-Cys14)
InChIKey
NHXLMOGPVYXJNR-ATOGVRKGSA-N
Solubility in water
100 mg/mL
References
[1]. Murray F, et al. Positive and negative contractile effects of somatostatin-14 on rat ventricular cardiomyocytes. J Cardiovasc Pharmacol. 2001 Mar;37(3):324-32. [2]. Bell D, et al. SRIF receptor subtype expression and involvement in positive and negative contractile effects of somatostatin-14 (SRIF-14) in ventricular cardiomyocytes. Cell Physiol Biochem. 2008;22(5-6):653-64.
* All products on our website are for scientific research and cannot be used in human body
Product details
Data download

Cyclic somatostatin (SRIF-14) is a growth hormone-release inhibiting factor used in the research of severe, acute hemorrhages of gastroduodenal ulcers. Cyclic somatostatin is a neuropeptide co-stored with acetylcholine in the cardiac parasympathetic innervation, exerts influences directly on contraction of ventricular cardiomyocytes. Cyclic somatostatin inhibits the contractile response of isoprenaline with an IC50 value of 13 nM. Cyclic somatostatin can be used for the research of cardiovascular disease.